Spero Therapeutics

SPRO

NASDAQHealth Care

Income Statement

Total Revenue$47.98M

Gross Profit$47.98M

Operating Income$-73.36M

EBITDA$-68.56M

EBIT$-68.57M

Pre-tax Income$15.5M

Net Income$-68.57M

Cash Equivalent$68.74M

Total Debt$4.78M

Book Value$72.09M

Book Value Per Share1.33

Return on Equity (ROE)-148.66%

Return on Assets (ROA)-62.03%

Return on Invested Capital (ROI)-148.66%

Net Profit Margin-142.91%

Current Ratio2.19

Quick Ratio2.15

Long-Term Debt / Equity0.00